EP1670901A4 - Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells - Google Patents

Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells

Info

Publication number
EP1670901A4
EP1670901A4 EP04782339A EP04782339A EP1670901A4 EP 1670901 A4 EP1670901 A4 EP 1670901A4 EP 04782339 A EP04782339 A EP 04782339A EP 04782339 A EP04782339 A EP 04782339A EP 1670901 A4 EP1670901 A4 EP 1670901A4
Authority
EP
European Patent Office
Prior art keywords
stem cells
neurons
vitro differentiation
primate embryonic
embryonic stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04782339A
Other languages
German (de)
French (fr)
Other versions
EP1670901A2 (en
Inventor
Su-Chun Zhang
James A Thomson
Ian David Duncan
Xue-Jun Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Publication of EP1670901A2 publication Critical patent/EP1670901A2/en
Publication of EP1670901A4 publication Critical patent/EP1670901A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/44—Thiols, e.g. mercaptoethanol
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/46—Amines, e.g. putrescine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/90—Polysaccharides
    • C12N2501/91—Heparin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Psychology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP04782339A 2003-08-29 2004-08-27 Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells Withdrawn EP1670901A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49883103P 2003-08-29 2003-08-29
US49957003P 2003-09-02 2003-09-02
PCT/US2004/027841 WO2005021720A2 (en) 2003-08-29 2004-08-27 Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells

Publications (2)

Publication Number Publication Date
EP1670901A2 EP1670901A2 (en) 2006-06-21
EP1670901A4 true EP1670901A4 (en) 2007-09-05

Family

ID=34278616

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04782339A Withdrawn EP1670901A4 (en) 2003-08-29 2004-08-27 Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells

Country Status (8)

Country Link
EP (1) EP1670901A4 (en)
JP (2) JP2007503811A (en)
KR (2) KR20060115351A (en)
AU (1) AU2004269361B2 (en)
CA (1) CA2536588C (en)
GB (1) GB2421029B (en)
IL (2) IL173832A (en)
WO (1) WO2005021720A2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7588937B2 (en) 2001-10-03 2009-09-15 Wisconsin Alumni Research Foundation Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells
US8153424B2 (en) 2001-10-03 2012-04-10 Wisconsin Alumni Research Foundation Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells
US7632679B2 (en) * 2002-07-16 2009-12-15 The Trustees Of Columbia University In The City Of New York Systems and methods for screening for modulators of neural differentiation
JP4792290B2 (en) * 2005-12-27 2011-10-12 財団法人 東京都医学総合研究所 Method for producing neural stem cells
CA2644922C (en) 2006-03-07 2019-07-23 Geeta Shroff Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
KR100838013B1 (en) * 2006-06-07 2008-06-12 제일약품주식회사 Efficient Generation of Neural Progenitors, Neurons and Dopaminergic Neurons from Human Embryonic Stem Cells
WO2009132156A1 (en) 2008-04-22 2009-10-29 Regenerative Research Foundation Retinal pigment epithelial stem cells
KR101168053B1 (en) * 2009-11-06 2012-07-24 연세대학교 산학협력단 Efficient and Universal Method for Neural Differentiation of Pluripotent Stem Cells
US20130149287A1 (en) 2010-07-30 2013-06-13 Cambridge Enterprise Limited Corticogenesis of Human Pluripotent Cells
US9487752B2 (en) 2011-03-30 2016-11-08 Cellular Dynamics International, Inc. Priming of pluripotent stem cells for neural differentiation
JP6015112B2 (en) * 2012-05-11 2016-10-26 株式会社ニコン Cell evaluation apparatus, cell evaluation method and program
PE20210451A1 (en) * 2015-11-12 2021-03-08 Hoffmann La Roche OLIGONUCLEOTIDES TO INDUCE PATERNAL EXPRESSION OF UBE3A
US11473061B2 (en) 2016-02-01 2022-10-18 Cedars-Sinai Medical Center Systems and methods for growth of intestinal cells in microfluidic devices
JPWO2017209290A1 (en) * 2016-06-03 2019-04-11 国立大学法人京都大学 Production and use of pluripotent stem cell-derived motor neurons
JP6376196B2 (en) * 2016-09-29 2018-08-22 株式会社ニコン Cell evaluation apparatus, cell evaluation method and program
US11913022B2 (en) 2017-01-25 2024-02-27 Cedars-Sinai Medical Center In vitro induction of mammary-like differentiation from human pluripotent stem cells
US11767513B2 (en) 2017-03-14 2023-09-26 Cedars-Sinai Medical Center Neuromuscular junction
US11414648B2 (en) 2017-03-24 2022-08-16 Cedars-Sinai Medical Center Methods and compositions for production of fallopian tube epithelium
CN108048399B (en) * 2017-11-13 2021-03-23 昆明医科大学 Method for inducing tree shrew dopamine neuron primary cell autophagy by METH
JP2019106895A (en) * 2017-12-15 2019-07-04 インダストリー‐ユニバーシティー コーぺレーション ファンデーション ハンヤン ユニバーシティ Method of differentiating neural stem cells or neural precursor cells into dopamine neurons
EP3775161A4 (en) * 2018-04-06 2022-04-06 Cedars-Sinai Medical Center Human pluripotent stem cell derived neurodegenerative disease models on a microfluidic chip
US11981918B2 (en) 2018-04-06 2024-05-14 Cedars-Sinai Medical Center Differentiation technique to generate dopaminergic neurons from induced pluripotent stem cells
WO2019236082A1 (en) * 2018-06-06 2019-12-12 The Regents Of The University Of California Neural stem cell compositions and methods to treat neurodegenerative disorders
JP6798533B2 (en) * 2018-07-26 2020-12-09 株式会社ニコン Cell evaluation device, incubator and program
WO2021045217A1 (en) * 2019-09-06 2021-03-11 学校法人慶應義塾 Method for producing cell aggregate including glial progenitor cells
JP7235027B2 (en) * 2020-11-16 2023-03-08 株式会社ニコン Cell evaluation instruments, incubators and programs

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001083715A2 (en) * 2000-05-01 2001-11-08 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the Secretary, Derivation of midbrain dopaminergic neurons from embryonic stem cells
WO2001088104A2 (en) * 2000-05-17 2001-11-22 Geron Corporation Neural progenitor cell populations
US20030068819A1 (en) * 2001-10-03 2003-04-10 Su-Chun Zhang Method of in vitro differentiation of transplantatable neural precursor cells from primate embryonic stem cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7144997B2 (en) * 1997-07-24 2006-12-05 Curis, Inc. Vertebrate embryonic patterning-inducing proteins, compositions and uses related therto
CA2298506A1 (en) * 1997-08-04 1999-02-11 The Regents Of The University Of California Methods for treating neurological deficits
CN100422315C (en) * 2000-11-30 2008-10-01 斯坦姆荣公司 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
US20030211605A1 (en) * 2001-05-01 2003-11-13 Lee Sang-Hun Derivation of midbrain dopaminergic neurons from embryonic stem cells

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001083715A2 (en) * 2000-05-01 2001-11-08 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the Secretary, Derivation of midbrain dopaminergic neurons from embryonic stem cells
WO2001088104A2 (en) * 2000-05-17 2001-11-22 Geron Corporation Neural progenitor cell populations
US20030068819A1 (en) * 2001-10-03 2003-04-10 Su-Chun Zhang Method of in vitro differentiation of transplantatable neural precursor cells from primate embryonic stem cells

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BAIN G ET AL: "Embryonic stem cells express neuronal properties in vitro", DEVELOPMENTAL BIOLOGY, ACADEMIC PRESS, NEW YORK, NY, US, vol. 168, no. 2, 1995, pages 342 - 357, XP002317725, ISSN: 0012-1606 *
LI X ET AL: "Differentiation of human embryonic stem cells into motoneurons.", SOCIETY FOR NEUROSCIENCE ABSTRACT VIEWER AND ITINERARY PLANNER, 2003, 33RD ANNUAL MEETING OF THE SOCIETY OF NEUROSCIENCE; NEW ORLEANS, LA, USA; NOVEMBER 08-12, 2003, pages ABSTRACT NO. 347.7, XP009087528, Retrieved from the Internet <URL:http://sfn.scholarone.com> [retrieved on 30070730] *
LI XUE-JUN ET AL: "Specification of motoneurons from human embryonic stem cells", NATURE BIOTECHNOLOGY, vol. 23, no. 2, February 2005 (2005-02-01), pages 215 - 221, XP009087451, ISSN: 1087-0156 *
MUJTABA T ET AL: "Lineage-restricted neural precursors can be isolated from both the mouse neural tube and cultured ES cells", DEVELOPMENTAL BIOLOGY, ACADEMIC PRESS, NEW YORK, NY, US, vol. 214, no. 1, 1 October 1999 (1999-10-01), pages 113 - 127, XP002216609, ISSN: 0012-1606 *
See also references of WO2005021720A2 *
YAN YIPING ET AL: "Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells", STEM CELLS (MIAMISBURG), vol. 23, no. 6, June 2005 (2005-06-01), pages 781 - 790, XP009087442, ISSN: 1066-5099 *

Also Published As

Publication number Publication date
GB2421029B (en) 2008-04-09
GB2421029A (en) 2006-06-14
WO2005021720A3 (en) 2005-05-19
JP2010162024A (en) 2010-07-29
GB0605851D0 (en) 2006-05-03
JP5529561B2 (en) 2014-06-25
CA2536588A1 (en) 2005-03-10
WO2005021720A2 (en) 2005-03-10
EP1670901A2 (en) 2006-06-21
IL173832A0 (en) 2006-07-05
KR20080109943A (en) 2008-12-17
JP2007503811A (en) 2007-03-01
CA2536588C (en) 2018-04-24
IL198450A (en) 2011-01-31
AU2004269361A1 (en) 2005-03-10
IL173832A (en) 2011-02-28
KR20060115351A (en) 2006-11-08
AU2004269361B2 (en) 2010-05-20

Similar Documents

Publication Publication Date Title
IL173832A0 (en) Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells
EP1534068A4 (en) Compositions and methods for neural differentiation of embryonic stem cells
GB2423774B (en) Method of culturing neurons, neuron culture substrate, neurons, neuron system, and method for manufacturing neuron system
AU2003227540A8 (en) Method for the production and the use of microparticles and nanoparticles by constructive micronisation
EP1695760A4 (en) Porous formed article and method for production thereof
EP1812556A4 (en) Neuronal progenitors from feeder-free human embryonic stem cell culture
IL174606A0 (en) Method of inducing the differentiation of stem cells into myocardial cells
GB2452667B (en) Efficient generation of neural progenitors, neurons and dopaminergic neurons from human embryonic stem cells
EP1613726A4 (en) Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells
IL173889A0 (en) In vitro generation of gabaergic neurons from embryonic stem cells and their use in the treatment of neurological disorders
GB2393733B (en) Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson&#39;s disease
EP1660629A4 (en) Automated cell culture system and process
ZA200401646B (en) Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells.
WO2005105986A3 (en) Neural cell differentiation method from es cells
WO2005017131A3 (en) Methods for the differentiation of human stem cells
AU2003249227A8 (en) Methods and systems for extended in vitro culture of neuronal cells
EP2341147A3 (en) Preprimitive streak and mesendoderm cells
EP1679367A4 (en) Fungus capable of controlling poaceous plant disease damage, and utilizing the same, controlling agent, method of controlling and biomaterial
ZA200602498B (en) In vitro generation of gabaergic neurons from embryonic stem cells and their use in the treatment of neurological disorders
EP1659103A4 (en) Charging material for producing refractory high-strength spherical granules and method for the production thereof
PL1658237T3 (en) Method for the comminution of particulate organic substances in suspensions of microorganisms
DE602004019055D1 (en) MEDICAMENT IN THE FORM OF FINE PARTICLES, METHOD AND DEVICE FOR ITS MANUFACTURE AND MEANS FOR PARENTERAL INJECTION AND PRODUCTION PROCESS THEREFOR
PL1647542T3 (en) Method for the production of metal carboxylates-aminoates and their use as growth promoters in animal feed
SI1663869T1 (en) Calco-magnesian aqueous suspension and method for the production thereof
GB0423037D0 (en) Process and plant for treating biomass

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060324

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20070807

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 5/02 20060101AFI20050526BHEP

Ipc: G01N 33/48 20060101ALI20070801BHEP

Ipc: C12N 5/08 20060101ALI20070801BHEP

Ipc: C12N 5/06 20060101ALI20070801BHEP

17Q First examination report despatched

Effective date: 20110527

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140808

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: C12N0005020000

Ipc: C12N0005079300

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: C12N0005020000

Ipc: C12N0005079300

Effective date: 20150107